Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Generic clindamycin approved by FDA

July 28, 1997

The Immune Response Corp. reports on T-cells involved in psoriasis

July 23, 1997

Life Medical Sciences discontinues venous stasis ulcer trial

July 23, 1997

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

Selective RAR-gamma ligands described by Roche

July 21, 1997

Multicenter European clinical trials of REPEL initiated

July 18, 1997

Novel antiinflammatory agents prepared by French investigators

July 17, 1997

Regranex recommended for approval by FDA advisory committee

July 16, 1997

Allergan prepares compounds with retinoid-like activity

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...